Previous Article | Next Article ![]()
Journal of Bacteriology, April 2006, p. 2554-2567, Vol. 188, No. 7
0021-9193/06/$08.00+0 doi:10.1128/JB.188.7.2554-2567.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Steffen Schaffer,2,
Michael Bott,2 and
Bernhard J. Eikmanns1*
Department of Microbiology and Biotechnology, University of Ulm, 89069 Ulm,1 Institute of Biotechnology 1, Research Center Jülich, D-52425 Jülich, Germany2
Received 1 December 2005/ Accepted 17 January 2006
|
|
|---|
|
|
|---|
C. glutamicum is able to grow on a variety of carbohydrates and organic acids as single or combined sources of carbon and energy, and among these substrates are glucose and acetate (31, 34). Based on biochemical, genetic, and regulatory studies; on quantitative determination of metabolic fluxes during utilization of acetate and/or glucose; and on genome-wide comparative expression analyses, there is considerable knowledge of enzymes and genes involved in acetate metabolism of C. glutamicum (reviewed in references 9 and 17). The utilization of acetate involves its uptake and subsequent activation to acetyl coenzyme A (CoA) and, when acetate is the sole carbon substrate, also requires the operation of the glyoxylate cycle as anaplerotic pathway. The key enzymes of acetate activation, acetate kinase (AK) and phosphotransacetylase (PTA), and those of the glyoxylate cycle, isocitrate lyase (ICL) and malate synthase (MS), have been intensively studied with respect to their biochemical properties as well to their regulation, and all four enzymes have been shown to be essential for the growth of C. glutamicum on acetate as the sole carbon and energy source (43, 44, 45, 49). The specific activities of AK, PTA, ICL, and MS in C. glutamicum are much higher in the presence of acetate in the growth medium than in its absence, and, as shown by Northern blot hybridization and transcriptional fusion experiments, as well as by DNA microarray technology, these differences in activity can be explained almost completely by coordinated transcriptional regulation of the respective genes (17, 20, 40, 45, 55). The AK and PTA genes (ack and pta, respectively) form an operon with pta upstream of ack (pta-ack operon [45]) and with transcriptional initiation at 159 and 47 bp (TS1 and TS2, respectively) upstream of the proposed pta translational start codon (17). The ICL and MS genes (aceA and aceB, respectively) are not located in the vicinity of the pta-ack operon; they are clustered on the chromosome, separated by 597 bp and transcribed in divergent directions (44). Kim et al. (29) recently described the GlxR protein, belonging to the cyclic AMP (cAMP) receptor protein family of transcriptional regulators and able to bind to the aceA/aceB intergenic region in the presence of cAMP. The overexpression of the glxR gene in C. glutamicum led to 10- to 15-fold-lower specific activities of ICL and MS when the cells were grown on acetate. Although the growth on acetate probably does not require a down-regulation of the glyoxylate cycle genes, these observations indicate that GlxR represents a repressor for the aceA and aceB genes. In accordance with coordinated expression control of the pta-ack operon, aceA, and aceB by a common regulator protein(s), we recently identified and characterized a novel transcriptional regulator (designated RamB) which, during growth of C. glutamicum in the absence of acetate, represses the expression of the four genes by specific binding to highly conserved 13-bp motifs (AA/GAACTTTGCAAA) in the pta-ack and the aceA/aceB promoter/operator regions (16). However, destruction of the 13-bp motif and, thus, prevention of the binding of the RamB protein to the aceA/aceB promoter region did not lead to complete deregulation of the respective promoter activities, and in a RamB-deficient mutant, there was still some residual regulation of the aceA and aceB genes (16). Moreover, cosubstrate experiments with glucose and with lactate in addition to acetate (55) revealed that aside from a negative effect of glucose and of lactate in the growth medium, there is a positive effect of acetate on the specific AK, PTA, ICL, and MS activities. These results suggested that in C. glutamicum, aside from RamB, an activator is involved in transcriptional control of the enzymes of acetate metabolism.
In the present study, we identified a novel LuxR-type transcriptional regulator, designated RamA, which is essential for growth of C. glutamicum on acetate and which activates the expression of the AK, PTA, ICL, and MS genes during growth in the presence of this carbon source. We show binding of purified RamA protein to the respective promoter/operator regions and, by deletion and mutation studies, present evidence for a consensus binding motif of RamA.
|
|
|---|
(19), E. coli BL21(DE3) (8), and the wild-type (WT) strain C. glutamicum ATCC 13032 were employed. Plasmids, their relevant characteristics and sources, and oligonucleotides used in this study are given in Table 1. The minimal medium used for C. glutamicum has been described previously (10) and contained 1% (wt/vol) acetate and/or 1% (wt/vol) glucose. Tryptone-yeast extract medium (2x) (46) was used as complex medium for C. glutamicum and for E. coli. When appropriate, kanamycin (50 µg ml1) was added to the medium. If not stated otherwise, C. glutamicum was grown aerobically at 30°C, E. coli at 37°C, as 50-ml cultures in 500-ml baffled Erlenmeyer flasks on a rotary shaker at 120 rpm. Growth of the bacteria was followed by measuring the optical density at 600 nm (OD600). |
View this table: [in a new window] |
TABLE 1. Plasmids and oligonucleotides used in this study
|
PCR techniques. PCR experiments were performed in a Biometra Personal Cycler (Biotron, Göttingen, Germany). Amplification of DNA was carried out with Vent polymerase (New England Biolabs, Schwalbach, Germany). Buffers and deoxynucleoside triphosphates were taken from MBI-Fermentas (St. Leon-Rot, Germany). Oligonucleotides (primers) were obtained from MWG-Biotech (Ebersberg, Germany) or from biomers.net GmbH (Ulm, Germany). Cycling times and temperatures were chosen according to fragment length and primer constitution. PCR products were separated on agarose gels and purified with the Nucleospin extract kit (Macherey Nagel, Düren, Germany).
DNA manipulation and Southern hybridization. Restriction enzymes, T4 DNA ligase, calf intestinal phosphatase, RNase A, proteinase K, and Taq polymerase were obtained from MBI-Fermentas and used as instructed by the manufacturer. DNA purification after restriction digestion was performed by separation on agarose gels and purification with the Nucleospin extract kit (Macherey Nagel). DNA hybridization experiments were performed as previously described (43). The complete ramA gene was amplified and labeled with digoxigenin-dUTP by PCR and used as a probe. Labeling, hybridization, washing, and detection were performed with the nonradioactive DNA Labeling and Detection kit and the instructions from Roche Diagnostics (Penzberg, Germany).
DNA affinity purification. The purification of DNA-binding proteins was performed essentially as described previously (14). Briefly, the pta-ack promoter/operator probe and the aceA/aceB promoter/operator probe were generated by PCR using plasmid pRob19 and oligonucleotides pta-bio and pta-16 (pta-ack probe) and plasmid pRob10 and oligonucleotides aceb1-bio and aceAB-rev (aceA/aceB probe). The primers pta-bio and aceb1-bio were tagged with biotin via a TEG linker (MWG-Biotech). Unincorporated oligonucleotides were removed by twofold ultrafiltration of the sample with Microcon-30 concentrators (Amicon, Witten, Germany). About 100 pmol of biotin-labeled PCR product was coupled to 3 mg of Dynabeads streptavidin (Dynal, Oslo, Norway), and uncoupled DNA was removed by magnetic separation according to the manufacturer's protocol. The coupled Dynabeads were stored at 4°C for a maximum of 1 week. Directly before incubation with the C. glutamicum crude extracts (see below), the coupled Dynabeads were equilibrated with 300 µl of binding buffer (20 mM Tris-HCl [pH 7.5], 1 mM EDTA, 1 mM dithiothreitol [DTT], 100 mM NaCl, 10% [vol/vol] glycerol, 0.05% [vol/vol] Triton X-100 [pH 8.0]) for 2 min.
Cultures (500 ml) of C. glutamicum were grown in acetate and glucose minimal medium, harvested at an OD600 of about 5, washed with 1 volume of TN buffer (50 mM NaCl, 50 mM Tris-HCl [pH 7.6]), and suspended in 6 ml of disruption buffer (50 mM Tris-HCl [pH 7.6], 1 mM DTT, 10 mM MgCl2, 1 mM EDTA, 10% [vol/vol] glycerol, 10 µM phenylmethylsulfonyl fluoride). Aliquots (1 ml) of the cell suspension were added to 2-ml screw-cap vials together with 250 mg of glass beads (150 to 212 µm; Sigma-Aldrich) and subjected six times for 25 s to mechanical disruption with a RiboLyser (setting, 6.5; Hybaid, Heidelberg, Germany) at 4°C with intermittent cooling on ice for 2 min. After disruption, glass beads and cellular debris were removed by two consecutive centrifugation steps at 13,000 x g and 4°C for 10 min and at 45,000 x g and 4°C for 60 min. The supernatant was concentrated by incubation (20 to 30 min) on solid polyethylene glycol 20000 in Visking dialysis tubes (Serva, Heidelberg, Germany) with a pore size of 25 Å. The dialyzed crude extract (about 500 µl), together with 10 µl of competitor DNA (herring sperm DNA, 10 mg/ml), was incubated with the coupled and equilibrated (see above) Dynabeads for 2 h at room temperature with shaking at 350 rpm. Unbound proteins were removed by magnetic separation with a magnet particle concentrator (Dynal) and two washes with 300 µl of binding buffer (see above). Subsequent elution of the DNA-bound proteins was done with binding buffer containing 0.3 and 1 M NaCl (20 µl each; magnetic separation was performed after each step). Eluted fractions were collected, and 10 µl of each was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by the technique of Laemmli (33). Gels were subsequently stained with the colloidal blue Coomassie staining kit (Novex, Frankfurt/Main, Germany).
Construction of plasmids for the synthesis and preparation of His-tagged RamA fusion protein. Vector pET28a was used for the synthesis of the hexahistidyl (His)-tagged RamA fusion protein. The ramA gene was amplified from chromosomal DNA of WT C. glutamicum by PCR with primers ramAf and ramAr. The PCR product was digested by NdeI and HindIII, ligated into the NdeI/HindIII-restricted plasmid pET28a, and transformed into E. coli BL21(DE3). The synthesis of the RamA protein carrying the His tag at itsNterminus was induced in recombinant E. coli BL21(DE3) (pET28-RamAx6His) by the addition of 1 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) after the culture had reached an OD600 of 0.6. The cells were grown for 4 h to an OD600 of about 5, harvested, and disrupted with a French pressure cell. Purification of the fusion protein was performed with Ni-nitrilotriacetic acid affinity chromatography according to the instructions of QIAGEN (Hilden, Germany). For desalting, the RamA fusion protein was dialyzed overnight against 30% (wt/vol) glycerol in water with Visking dialysis tubes (Serva) with a pore size of 25 Å. The fusion protein was then used directly for the promoter/operator binding assay.
Promoter/operator binding assays with His-tagged RamA fusion protein. The binding of the His-tagged RamA protein to the pta-ack and aceA/aceB promoter/operator regions was tested by DNA electrophoretic mobility shift assay (EMSA) using the DNA fragments or double-stranded oligonucleotides indicated and shown in Results. The DNA fragments were generated by PCR and purified by the Nucleospin extract kit (Macherey Nagel). For generating native and mutated double-stranded oligonucleotides, the two complementary primers were mixed and heated to 95°C for 10 min in TE buffer (10 mM Tris [pH 7.8], 1 mM EDTA) and allowed to anneal by slow cooling at room temperature. In the binding assays, 50 to 100 ng of the fragments or oligonucleotides was incubated with various amounts of RamA (0 to 2 µg) in 20 µl of 10 mM Tris-HCl reaction buffer, pH 7.6, containing 50 mM NaCl, 1 mM DTT, 1 mM EDTA, 10% (wt/vol) glycerol, and 1 µg of poly(dI-dC) for 20 min at room temperature. When indicated, acetate, acetyl-P, acetyl-CoA, free CoA, cAMP, cGMP, 2-oxoglutarate, NAD, NADH, ADP, and ATP were added at the final concentrations indicated in Results. Subsequently, the mixture was separated on a 2% agarose gel in 1x TAE buffer (200 mM Tris-HCl [pH 7.5], 100 mM acetate, 5 mM EDTA) at 70 V and 80 mA and stained with ethidium bromide.
Construction of a ramA mutant. To construct a ramA mutant of C. glutamicum, two DNA fragments were generated by PCR using the oligonucleotide pairs ramA1/ramA2, creating a 588-bp fragment covering 87 bp upstream of the ramA start codon and 478 bp of the 5' end of ramA, and ramA3/ramA4, creating a 582-bp fragment covering the region between 58 bp and 618 bp downstream of the TGA stop codon. The two fragments were ligated with PCR-generated BamHI restriction sites, thereby creating a fragment containing a 3'-truncated ramA gene (lacking 364 bp). The deduced polypeptide of this truncated ramA gene should be devoid of a functional helix-turn-helix (HTH) motif. Using the flanking 5' HindIII and 3' EcoRI restriction sites of the fragment, the construct was ligated into pK19mobsacB and transformed into C. glutamicum by electroporation. The truncated ramA gene then was introduced into the C. glutamicum genome by homologous recombination (double crossover) according to a protocol described by Schäfer et al. (47). The deletion in the resulting strain, C. glutamicum RG2, was confirmed by PCR (using primers ramA1 and ramA4; data not shown) and by Southern blot analysis. For the latter, BamHI-restricted chromosomal DNA from WT C. glutamicum and C. glutamicum RG2 was hybridized to a labeled ramA probe covering the entire open reading frame, resulting in a signal of about 5.3 kb with DNA from the ramA mutant and a signal of about 6.8 kb with DNA from the WT strain. According to the restriction map of the ramA gene region, these sizes were expected.
Construction of cat fusions. The construction and sequence validation of cat fusions with the pta-ack, aceA, and aceB promoter regions in plasmid pET2, i.e., of plasmids pRob19, pRob1, and pRob10, were described previously (16).
Enzyme assays. To determine enzyme activities in cell extracts, C. glutamicum cells were grown in minimal medium to the exponential growth phase, washed twice in 20 ml of 50 mM Tris-HCl buffer, pH 7.8, and resuspended in 1 ml of the same buffer containing 10 mM MgCl2, 1 mM EDTA, 1 mM DTT (except for determination of chloramphenicol acetyltransferase [CAT] activity), and 30% (vol/vol) glycerol. The cell suspension was added to 2-ml screw-cap vials together with 250 mg of glass beads (150 to 212 µm; Sigma-Aldrich), and the cells were disrupted with the RiboLyser as described above. After disruption, glass beads and cellular debris were removed by two consecutive centrifugation steps (13,000 x g, 4°C, 10 min, and 45,000 x g, 4°C, 60 min) and the supernatant was used for the assays. The Biuret method (18), with bovine serum albumin as the standard, was used to determine protein concentrations.
The specific enzyme activities of CAT, AK, PTA, ICL, and MS were determined exactly as described before (16).
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
For peptide mass fingerprinting, the protein bands of interest (each approximately 5 by 1.5 by 1 mm in size) were excised from colloidal Coomassie-stained gels with a scalpel and subjected to in-gel digestion with trypsin as described previously (16). Peptides were extracted by sequential addition of 12 µl of water and 10 µl of 0.1% (vol/vol) trifluoroacetic acid (TFA) in 30% (vol/vol) acetonitrile (ACN); 0.5 µl of the resulting peptide solution was mixed on a stainless steel sample plate with 0.5 µl of a saturated
-cyano-4-hydroxy-trans cinnamic acid solution in 50% (vol/vol) ACN-0.1% (vol/vol) TFA. Extraction of the peptides and close external calibration of each sample were also performed as described before (16). Samples were analyzed manually in positive reflector mode with 20-kV accelerating voltage and 63% grid voltage, with the delay time set at 125 ns. Data acquisition and analysis were performed with Voyager Control Panel software, version 5.0, and Voyager Data Explorer software, version 3.5 (Applied Biosystems). The generated mass lists were used to search the nonredundant NCBI database using MS-Fit (6).
Computational analysis. The search for protein domains was performed by using SMART (Simple Modular Architecture Research Tool) (48), NPS@ (Network Protein Sequence Analysis) (7), and the Pfam protein families database (2). Alignments were carried out by using BLAST (basic local alignment search tool) (1).
|
|
|---|
G [25°C] = 14.8 kcal mol1). The deduced protein consists of 281 amino acids and has a predicted molecular mass of 30.8 kDa, which corresponds well with the experimentally determined mass of the protein isolated by DNA affinity chromatography (Fig. 1). A putative HTH motif identified at the C terminus (amino acid positions 214 to 274) shows a high degree of amino acid sequence similarity with HTH motifs from known LuxR-like regulators (see Discussion). Therefore, the protein likely represents a LuxR-type transcriptional regulator. As the protein controls the expression of the pta-ack operon and of the aceA and aceB genes (see below), we designated it RamA (for "regulator of acetate metabolism A"), with the corresponding gene designated ramA.
![]() View larger version (47K): [in a new window] |
FIG. 1. SDS-PAGE of C. glutamicum proteins eluted from a DNA affinity chromatography experiment using pta-ack (A) and aceA/aceB (B) promoter/operator probes. The proteins in lanes 1 and 2 were eluted with 0.3 M NaCl, and those in lanes 3 and 4 were eluted with 1 M NaCl. The protein fractions applied to lanes 1 and 3 were obtained with cell extracts from acetate-grown cells of WT C. glutamicum, and those applied to lanes 2 and 4 were from glucose-grown cells. The proteins in bands a to h in panel A and i and j in panel B were identified by MALDI-TOF MS and peptide mass fingerprint analysis, and the assignments are given in the text. The molecular mass standard (lane M) is given to the right.
|
Inactivation of ramA in C. glutamicum and effect on growth. To functionally analyze the RamA protein of C. glutamicum, we constructed the ramA mutant C. glutamicum RG2. In this mutant, the ramA gene is shortened by 364 bp and encodes a 3'-truncated RamA protein without the HTH motif. Successful deletion within the ramA gene was confirmed by PCR and by Southern blot analysis (see Materials and Methods).
C. glutamicum RG2 and the parental WT strain were tested for growth on different media (Fig. 2). The mutant showed a growth rate similar to that of the WT (µ, 0.53 h1 versus 0.5 h1) during exponential growth on minimal medium containing glucose (Fig. 2A); however, it entered the stationary phase earlier than the wild-type and the final OD600 was lower (18 versus 24). In minimal medium containing acetate as the sole substrate, the ramA mutant RG2 was not able to grow (Fig. 2B). In minimal medium containing glucose plus acetate, the mutant initially showed the same growth rate as the WT strain (µ, 0.52 h1). After having reached an OD600 of about 17, the growth rate of the mutant decreased and it entered the stationary phase. The final cell density of the mutant was lower than that of the WT (OD600, 23 versus 35) (Fig. 2C). These results show that the RamA protein is essential for growth of C. glutamicum on acetate and suggest that it is also directly or indirectly involved in metabolic pathways that are relevant for glucose catabolism.
![]() View larger version (9K): [in a new window] |
FIG. 2. Growth of WT C. glutamicum (black circles) and the ramA mutant RG2 (gray triangles) in minimal medium containing 1% glucose (A), 1% acetate (B), or 1% glucose plus 1% acetate (C). Substrate concentrations are as indicated in Materials and Methods.
|
![]() View larger version (13K): [in a new window] |
FIG. 3. Specific activities of PTA, AK, ICL, and MS of WT C. glutamicum and the ramA mutant C. glutamicum RG2 in crude extracts of cells grown in minimal medium containing acetate (black bars), glucose and acetate (gray bars), or glucose (white bars). The activities given represent mean values ± standard deviations for at least three independent cultivations and two determinations per experiment.
|
|
View this table: [in a new window] |
TABLE 2. Specific CAT activities of WT C. glutamicum and C. glutamicum RG2 cells carrying the pta-ack, aceA, and aceB promoter fragments in plasmids pRob19, pRob1, and pRob10, respectively, and grown in minimal medium containing acetate and glucose or glucose alone as the carbon and energy source
|
![]() View larger version (41K): [in a new window] |
FIG. 4. Genomic locus of the pta-ack promoter region and DNA fragments used for mapping of the RamA binding sites (A) and representative EMSAs using RamA protein and different DNA fragments (B). (A) Transcriptional start sites for the pta-ack operon are designated TS 1 and TS 2, and the two RamB binding sites are designated 13-bp motif 1 and 13-bp motif 2. The fragments used for the binding assays are given as bars and designated as indicated to the left. Also indicated are binding (+, ++, and thicker bars) and nonbinding ( and thinner bars) of the respective fragments. + and ++ indicate the observation of one or two RamA/DNA complexes, respectively. The circled M's in fragment 1mut indicate that the 13-bp motifs were destroyed by mutation. At the bottom of the panel, the nucleotide sequences of fragments pta-1 and pta-2 are given. fprA represents a gene encoding a protein with similarity to ferredoxin NADP reductase from Mycobacterium tuberculosis. (B) The fragments used in the EMSAs are indicated below the different parts of the gels. Lanes 1 to 4 show EMSAs using 0, 0.25, 0.5, and 1 µg of RamA protein, respectively, and lane 5 shows an EMSA using 2 µg of bovine serum albumin. For details of the EMSAs, see Materials and Methods.
|
![]() View larger version (40K): [in a new window] |
FIG. 5. Genomic locus of the aceA/aceB intergenic promoter region and DNA fragments used for mapping of the RamA binding sites (A) and representative EMSAs using RamA protein and different DNA fragments (B). (A) Transcriptional start sites of aceA and aceB are designated TSaceA and TSaceB, respectively, and the RamB binding site is designated the 13-bp motif. The fragments used for the binding assays are given as bars and designated as indicated to the left. Also indicated are binding (+, ++, and thicker bars) and nonbinding ( and thinner bars) of the respective fragments. + and ++ indicate the observation of one or two RamA/DNA complexes, respectively. The circled M in fragment 2mut indicates that the 13-bp motif was destroyed by mutation. At the bottom of the panel, the nucleotide sequences of fragments ace-1 and ace-2 are given. (B) The fragments used in the EMSAs are indicated below the different parts of the gels. Lanes 1 to 4 show EMSAs using 0, 0.25, 0.5, and 1 µg of RamA protein, respectively; lane 5 shows an EMSA using 2 µg of bovine serum albumin. For details of the EMSAs, see Materials and Methods.
|
To test for involvement of the RamB binding site (i.e., the 13-bp motifs indicated in Fig. 4A and 5A) in binding between the purified RamA and the pta-ack and aceA/aceB promoter regions, we performed EMSAs using respective promoter fragments with mutagenized 13-bp motifs, i.e., fragments 1mut and 2mut in Fig. 4A and 5A, respectively. As shown in Fig. 4B and 5B, the RamA protein was retarded by both of these probes, indicating that RamA binds to sites different from the RamB binding sites.
Successive fragmentation and shortening of the pta-ack and aceA/aceB promoter fragments and employment of these fragments in EMSAs led to the identification of shorter promoter regions still forming two RamA/DNA complexes (e.g., fragments 1a and 2a in Fig. 4B and 5B, respectively) and of promoter regions forming only one RamA/DNA complex (e.g., fragments 1a6 and 1a10 in Fig. 4B and fragments 2a3 and 2a12 in Fig. 5B). The results indicated that the former regions carry two RamA binding sites and that the latter carry only one RamA binding site. The use of PCR-generated DNA fragments finally led to the identification of (i) two separate DNA fragments of the pta-ack promoter region (fragments pta-1 and pta-2 in Fig. 4A) and (ii) two separate DNA fragments of the aceA/aceB promoter region (fragments ace-1 and ace-2 in Fig. 5A), all four of which are shifted by the RamA protein (Fig. 6B, left-hand panels) and form a single RamA/DNA complex. Fragments pta-1 and pta-2 are separated by only 18 bp and centered 135 and 85 bp upstream of the distal transcriptional start site (TS 1 in Fig. 4A) of the pta-ack operon. Fragments ace-1 and ace-2 are separated by 137 bp and centered 72 bp and 235 bp upstream of the aceA transcriptional start site and 52 and 215 bp downstream of the aceB transcriptional start site (TSaceA and TSaceB in Fig. 5A). All four fragments contained a common stretch of four to six G residues flanked by T or C residues and, within a distance of four or five nucleotides, a further stretch of four to five G or C residues flanked by A, C, or T residues (Fig. 4A and 5A).
![]() View larger version (36K): [in a new window] |
FIG. 6. Alignment of the native pta-1, pta-2, ace-1, and ace-2 fragments with their derivatives possessing base substitutions in either one or both of the G/C stretches (A) and EMSAs using RamA protein and these DNA fragments (B). In panel A, the native G/C stretches are underlined and the base substitutions in the derivatives are shown in lowercase letters. In panel B, the DNA fragments used are indicated above the different parts of the gels. Lanes 1 to 4 show EMSAs using 0, 0.25, 0.5, and 1 µg of RamA protein, respectively.
|
The aceA/aceB fragment 2a12, containing the ace-2 RamA binding site, was employed to test for possible physiological effectors influencing the binding of RamA. For this purpose, EMSAs were performed using 0 to 1.0 µg of RamA incubated with 0.2 mM acetate, acetyl phosphate, acetyl-CoA, free CoA, 2-oxoglutarate, cAMP, cGMP, NAD, NADH, or 3 mM ATP or ADP. As shown in Fig. 7, none of the metabolites tested led to abolition or to a drastic increase of RamA binding to the fragment. However, it should be noted that shifting of the DNA fragment reproducibly required slightly higher concentrations of RamA protein when incubated with acetyl-CoA and slightly lower concentrations of RamA when incubated with ATP and ADP (Fig. 7). Although the latter results may hint at slight influences of acetyl-CoA, ATP, and ADP on RamA binding to its operator region, our results suggest that none of the metabolites tested is a major effector for expression control by the RamA protein.
![]() View larger version (99K): [in a new window] |
FIG. 7. EMSAs using the aceA/aceB fragment 2a12 and RamA protein incubated in the absence and presence of 200 µM acetate (Ac), acetyl phosphate (AcP), acetyl-CoA (AcCoA), free CoA (CoA), 2-oxoglutarate, cAMP, cGMP, NAD, NADH, or 3 mM ATP or ADP. Lanes 1 to 6 indicate EMSAs using 0, 0.06, 0.125, 0.25, 0.5, and 1.0 µg of RamA protein, respectively.
|
|
|
|---|
As evident from our comparative growth experiments with WT C. glutamicum and RG2, RamA is essential for growth of this organism on acetate. The inability of the ramA mutant to grow on acetate as the sole carbon and energy source can be explained by the almost complete loss of ICL and MS activities. However, strain RG2 also showed a lower final OD600 when cultivated on glucose minimal medium. Since ICL and MS are not essential for growth on glucose (43, 44), the growth phenotype of the ramA mutant under these conditions cannot be explained by the lack of the two enzymes. Instead, it can be assumed that RamA somehow controls the expression of enzymes involved in glucose metabolization. However, there is so far no experimental evidence of RamA-directed control of glucose metabolism, and further studies are necessary to clarify the significance of RamA for expression of genes other than aceA, aceB, and pta-ack.
BLAST databank analyses with the deduced amino acid sequence of RamA revealed significant identity of this protein with putative regulatory proteins from other corynebacteria, i.e., with CE2445 from C. efficiens (95% identity), DIP1889 from C. diphtheriae (81%), and JK0397 from C. jeikeium (76%). RamA also shows 45% sequence identity to a putative LuxR-type regulator (BAC69743) from Streptomyces avermitilis and to a putative response regulator (SCO6194; CAB36602) from Streptomyces coelicolor. However, none of the proteins with similarity to RamA have yet been functionally characterized; thus, the regulatory role of any of these proteins remains speculative. BLAST searches, as well as SMART analysis, revealed the presence of a typical LuxR-type HTH motif at the C terminus of RamA (amino acids 214 to 274) showing 30 to 50% identity to the HTH motifs of LuxR-type transcriptional regulators such as LuxR from Vibrio fischeri, Rhodoferax ferrireducens, Chloroflexus aurantiacus, and other bacteria; GerE from Bacillus subtilis; and MalT and MalT-like proteins from E. coli and other prokaryotes. In these transcriptional activators, which belong to the LuxR-FixJ protein family, the HTH motif in general is located at the C terminus of the respective proteins and has been shown to be important for DNA binding (54). Due to the presence of the LuxR-type HTH motif in the C-terminal domain, and in agreement with the HTH position/function relationship postulated by Perez-Rueda et al. (42), the C. glutamicum RamA protein, with its HTH motif at its C terminus, likely would represent an activator protein. This assumption has been verified here by characterization of the ramA mutant C. glutamicum RG2 and by the transcriptional fusion experiments.
Further analysis of the RamA protein sequence using the Pfam HMM database revealed that the N terminus (amino acids 8 to 146) of RamA shows similarity to GAF domains found in cGMP-specific phosphodiesterases in prokaryotes and eucaryotes, in cyanobacterial and plant phytochromes, in adenylyl cyclase from Anabaena, and in the formate hydrogen lyase transcriptional activator FhlA from E. coli (13, 22, 23, 38). The GAF domains are known to bind small molecules such as cAMP and cGMP (22, 38, 50), formate (23), and/or 2-oxoglutarate (36, 39). Since in many bacteria cyclic nucleotides are involved as signaling molecules in the regulation of gene expression in response to environmental stimuli (including the carbon source) (4, 6, 12, 15, 37), and since 2-oxoglutarate has been implicated as a key metabolic signal of carbon status (41), cAMP, cGMP, and 2-oxoglutarate were attractive candidates as potential metabolic effector(s) controlling the activity of RamA. However, we did not observe any significant effect of cAMP, cGMP, or 2-oxoglutarate on the DNA-binding activity of RamA; thus, it remains unclear whether the GAF domain in RamA has a function in triggering its regulatory function.
Since our DNA affinity chromatography revealed the presence of RamA in both glucose- and acetate-grown cells of C. glutamicum, it can be expected that RamA function is triggered by an effector which is specific for the one or the other growth condition. To identify this effector for RamA activity (or inactivity), we further tested acetate, acetyl phosphate, acetyl-CoA, free CoA, NAD, NADH, ATP, and ADP for their effect on the DNA-binding activity of RamA. Except for NAD and NADH, all of these metabolites are involved in acetate activation during growth of C. glutamicum on acetate and thus were possible effector candidates. However, under the conditions employed, none of these candidates showed a significant positive or negative effect on the DNA binding of RamA, indicating that none of them represents the direct physiological trigger of the transcriptional regulation brought about by RamA.
As is the case with RamA, the RamB repressor protein binds to the promoter/operator regions of the pta-ack operon and of aceA/aceB, and so far, we had been unable to identify a metabolite preventing or increasing its binding activity (16). In contrast, the glyoxylate bypass regulator GlxR contains a domain with similarity to cAMP binding motifs, and in fact, cAMP was shown to be essential for binding of GlxR to the aceA/aceB intergenic region (29). Since C. glutamicum showed a higher intracellular cAMP level during growth in glucose medium than during growth in acetate medium, Kim et al. speculated that GlxR may repress the glyoxylate bypass genes in the presence of glucose; however, overexpression of the glxR gene in C. glutamicum had no effect on the specific ICL and MS activities when grown in glucose medium but surprisingly resulted in ten- to fifteenfold reductions of these activities when the cells were grown in acetate medium (29). This obvious repression of the ICL and MS genes in acetate-grown cells of C. glutamicum certainly does not reflect the physiological situation, and Kim et al. explained the result by the multicopy effects of glxR. Unfortunately, so far it has not been possible to obtain and analyze a glxR mutant (29). Thus, although the available data suggest that GlxR represents a cAMP-triggered repressor for expression of the aceA and aceB genes, the physiological function and the mechanism of expression control by GlxR remain to be clarified.
Using subfragments and mutational analysis, two RamA binding sites were identified upstream of the pta-ack operon and two in the aceA/aceB intergenic region. Alignment of the corresponding sequences revealed a minimal consensus sequence consisting of tandem A/C/TG4-6T/C or AC4-5A/G/T stretches separated by four or five arbitrary nucleotides. Although we also observed partial retardation in our EMSAs with fragments mutated in one of the stretches, we regard the tandem stretches as the physiological binding site, since complete retardation was observed only when the fragments contained two intact half sites. The two RamA binding sites within the promoter/operator regions are separated by different distances, and all of the sites vary in location with respect to the transcriptional start site(s) of the target genes. In the cases of the pta-ack operon and of aceA, the identified binding sites are located upstream of the transcriptional start sites (that of pta-ack is centered 134 and 87 bp upstream of TS1 and 246 and 199 bp upstream of TS2; that of aceA is centered 236 and 72 bp upstream of the transcriptional start), whereas they are located downstream (50 and 218 bp) of the transcriptional start site in the case of aceB (Fig. 4A and 5A). Therefore, the question of how RamA activates expression of the target gene, despite this variance in binding location, arises. One possibility is that RamA somehow interacts with (DNA-bound) RamB and/or with an additional, hitherto unidentified protein. Such an interaction might lead to tertiary DNA structures facilitating (or preventing) access of the RNA polymerase and thus allowing (or preventing) gene expression. A point in favor of an interaction between RamA and RamB may be that the respective binding sites are located close to one another (Fig. 4A and 5A). However, we have so far no experimental evidence for a protein-protein interaction involving RamA. Another possibility is the formation of tertiary DNA structures brought about by binding of RamA to two or more binding sites. The presence of two binding sites in both the pta-ack and aceA/aceB promoter regions may allow the formation of DNA loop structures, and these again may have an influence on the binding and/or activity of the RNA polymerase.
With respect to the nature and location of the consensus motif proposed here for the C. glutamicum RamA binding site, the relatively low but significant similarity (30% identity) of the RamA C terminus and the LuxR-type HTH of the MalT proteins from E. coli and from Klebsiella pneumoniae must be mentioned again (see also above). MalT is a transcriptional LuxR-type activator for maltose-inducible operons, it is activated by maltotriose and ATP, and it recognizes the nucleotide sequence 5'-GGGGAT/GGAGG-3' as a binding site (5, 54). All promoters of the K. pneumoniae maltose regulon contain pairs of this binding site in direct repeat and separated by three nucleotides (54). This tandem organization of the motifs, the variation of the binding sites in location and orientation with respect to the transcriptional start sites of target genes, and the fact that the consensus sequence of the MalT binding site shares the long stretch of G residues with the RamA binding motif may indicate that the regulatory mechanisms of MalT and RamA are somehow related.
Recent DNA microarray experiments using RNA from C. glutamicum cells grown on glucose or acetate revealed, aside from the pta-ack operon and the aceA and aceB genes, about 55 genes with different amounts of transcript (17, 20, 40). Among these genes/operons were those for several enzymes of the central metabolism of C. glutamicum, e.g., for some of the tricarboxylic acid cycle enzymes and for some involved in sugar metabolism of this organism. For 11 of these genes belonging to the acetate stimulon, we showed the 13-bp RamB binding motif (with up to five mismatches) to be present in their promoter regions, and we therefore suggested that RamB might have broader significance in controlling the central metabolism of C. glutamicum (16). Since it is reasonable to speculate that RamA is also involved in expression control of genes belonging to the acetate stimulon, we analyzed the 800-bp upstream regions of all of those candidate genes for the presence of the pair of NG4-6TN or NC4-5N stretches, allowing a separation of up to six nucleotides. This analysis revealed the presence of tandem motifs upstream of the succinate dehydrogenase operon sdhCAB (TG5T N2 TG5A, centered 71 bp upstream of the start codon), of the aconitase gene acn (TG5 N5 AG5T, centered 280 bp upstream of the start codon and 170 bp upstream of the main acn transcriptional start site) (32), and of the phosphoenolpyruvate carboxykinase gene pck (TG4T N4 TG4A, centered 602 bp upstream of the start codon). The promoter regions of all three genes, sdhCAB, acn, and pck, also contain a typical RamB binding site (16), suggesting that these genes, together with the pta-ack operon and the aceA and aceB genes, are controlled by coordinated action of RamA and RamB. However, further studies are required to experimentally prove the functionality of the putative RamA and RamB binding sites in front of the sdhCAB, acn, and pck genes and to clarify the relevance of the RamA and RamB proteins for expression control of these genes.
By comparison of the expression profiles of the WT of C. glutamicum and of a mutant defective in the regulator-of-iron proteins (RipA), Wennerhold et al. (56) recently found that the mutant contained increased levels of pta mRNA under iron starvation. Moreover, these authors showed binding of the RipA protein to two conserved RipA binding motifs in the pta-ack promoter region. These binding motifs are centered at positions 111.5 and +156.5 with respect to the transcriptional start site TS1 of the pta-ack operon and thus do not interfere with either the RamA or the RamB binding site. Although we used a pta-ack promoter fragment containing one of the RipA binding sites, we did not observe RipA in our DNA affinity enrichments. In fact, we did not expect to enrich the RipA protein, since we grew our cultures under an excess of iron and it had been shown that expression of the ripA gene is repressed under iron excess (by the global iron repressor DtxR) and derepressed under iron starvation (32, 56). However, although not relevant under the conditions applied here, all of the findings show that the operon encoding AK and PTA is not only influenced by the carbon source (i.e., under control of RamA and RamB) but also regulated by the iron content of the medium, i.e., under indirect and direct control of DtxR and RipA, respectively.
From the results of this and other very recent studies of the regulation of the acetate metabolism of C. glutamicum, it becomes evident that the genes encoding AK, PTA, ICL, and MS are under the control of a variety of transcriptional regulators, i.e., RamA, RamB, GlxR, DtxR, and RipA (16, 29, 56). These regulators obviously permit the adaptation of this industrially important organism to specific extracellular and intracellular nutritional environments. However, many questions about the molecular mechanism of activation and repression, the signals involved, and the interplay of the regulatory proteins remain to be answered by further investigations.
|
|
|---|
Present address: Degussa AG, Project House ProFerm, D-33790 Halle/Westfalen, Germany. ![]()
Present address: Degussa AG, Project House ProFerm, D-63457 Hanau-Wolfgang, Germany. ![]()
|
|
|---|
a new purification principle for the ultrarapid isolation of near homogeneous factor. Nucleic Acids Res. 17:6253-6267.
54-dependent transcriptional activator FHLA from Escherichia coli. J. Bacteriol. 177:2798-2803.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»